<DOC>
	<DOCNO>NCT01232322</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy long term treatment drug child age 6 month &lt; 5 year bronchial asthma daily clinical usage .</brief_summary>
	<brief_title>Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients treat Pulmicort Respules first time due bronchial asthma Children &gt; = 6 month &lt; 5 year old age start study treatment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>bronchial asthma</keyword>
	<keyword>Pulmicort Respules</keyword>
	<keyword>long term use</keyword>
	<keyword>pediatrics</keyword>
</DOC>